Brief: Compass Therapeutics Reports 2026 Third Quarter Financial Results

BRIEF-Compass Therapeutics Reports 2026 Third Quarter Financial Results 

-

  • COMPASS THERAPEUTICS Q3 BASIC EPS USD -0.15

  • COMPASS THERAPEUTICS Q3 NET INCOME USD -27.171 MILLION

  • COMPASS THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -28.8 MILLION

Source text: ID:nGNX8njxd4


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Compass Therapeutics

See all news